Connecticut HB05482 mandates twelve-month coverage for contraception and hormone therapy prescriptions.

Connecticut HB05482 requires both public and private insurance to cover a twelve-month supply of contraception and prescription hormone therapy. This applies to policies delivered, issued, renewed, or amended in the state starting January 1, 2027. Prescription hormone therapy includes FDA-approved drugs used to suppress, increase, or replace hormones, excluding glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists.

Connecticut HB05482 mandates twelve-month coverage for contraception and hormone therapy prescriptions.

Connecticut HB05482 requires both public and private insurance to cover a twelve-month supply of contraception and prescription hormone therapy. This applies to policies delivered, issued, renewed, or amended in the state starting January 1, 2027. Prescription hormone therapy includes FDA-approved drugs used to suppress, increase, or replace hormones, excluding glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists.